Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Is (TLRY) Outperforming Other Medical Stocks This Year?

Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?

Beazer Homes USA

JPMorgan Chase & Co

NVIDIA

Tesla

We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).

Here're the 5 Top Stock Trades for 2021

Aurora Cannabis

Aphria

Curaleaf Holdings, Inc.

When is the right time to buy stock in the cannabis market? The time is now!

The Future of Cannabis Stocks in 2021

Tilray (KL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Tilray (KL) Looks Good: Stock Adds 5.3% in Session

HEXO Corp

SNDL Inc.

Marijuana is now widely legal, and the industry will soon be gobbling up market share from its illicit competition.

Is 2021 the Year to Buy Into the Cannabis Stock Hype?

OrganiGram Holdings Inc.

Investors think the new administration in the U.S. could bring an inflection point for the industry.

Why Aurora Cannabis, Aphria, and Other Cannabis Stocks Rose Again Today

Canopy Growth

Amplify Seymour Cannabis ETF

Cronos Group

Amplify Alternative Harvest ETF

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Cannabis stocks rallied anew on Thursday, with the Cannabis ETF on track for its biggest weekly gain since March of 2020, as hopes the Democrat's victory in the Georgia Senate run-off will spur the reforms needed to allow the legal sector to flourish.

Cannabis Watch: Cannabis stocks rally anew after Democrats win Georgia Senate race

Marathon Digital Holdings

Plug Power

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Here's Why Plug Power, Aurora, Tilray and Marathon Patent Stock Is Moving

Investors in the cannabis sector are feeling pretty good today.

Here's Why Tilray, Canopy Growth, Aphria, and HEXO All Soared Today

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Predicting market moves proves difficult again, but cannabis investors have high hopes for the future.

Pot Stocks Are on a Big Election High as Markets Jump

GrowGeneration Corp

Village Farms International

The marijuana industry's growth could be about to accelerate.

Why Sundial, Grow Generation, and Other Cannabis Stocks Skyrocketed Today

Cannabis stocks staged a strong rally on Wednesday, with most Canadian and U.S. companies posting double-digit percentage gains, buoyed by hopes the Democrats may take the Senate and pursue a more pro-reform agenda.

Cannabis Watch: Cannabis stocks stage strong rally as prospect of Democratic Senate spurs reform hopes

Cannabis stocks surged on Wednesday as Democrats won a key U.S. Senate race in Georgia and led in another, moving closer to a stunning sweep that would give them control of Congress and power to act on their promise to legalize pot.

Pot stocks high as Democrats on brink of controlling U.S. Senate

Cannabis stocks Tilray, Canopy Growth and ACB are up in double digits as the Georgia runoff elections appear to flip the U.S. Senate blue. The post Cannabis Stocks: Why TLRY, CGC and ACB Stock Are on the Move appeared first on InvestorPlace.

Cannabis Stocks: Why TLRY, CGC and ACB Stock Are on the Move

The final weeks of 2020 brought a host of market-shaking headlines. However, one major headline only  received a brief moment of scrutiny before getting subsumed by news of federal stimulus and COVID-19 updates, and that was the landmark congressional vote on decriminalizing marijuana on a federal level.

Cultivating A Cannabis Portfolio For A Green New Year

Cannabis stocks rallied in premarket trade Wednesday, on hopes the Democrats may take the Senate after Raphael Warnock won one of two Senate runoffs in Georgia early Wednesday, according to the Associated Press, bringing Democrats a seat closer to a Senate majority. With 97% of the expected vote total reported, Democratic challenger Jon Ossoff was leading Republican Sen.

Cannabis stocks stage strong premarket rally on hopes the pro-reform Democrats may take the Senate

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?

A positive analyst note was the apparent spark that lit a broad sector rally.

Why Marijuana Stocks Tilray, HEXO, and Charlotte's Web Were on Fire Monday

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Cambria Cannabis ETF

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry.

Cannabis Stocks: Outlook For 2021 And What To Look For

iShares MSCI Israel ETF

VanEck Vectors Israel ETF

Amplify BlueStar Israel Technology ETF

ARK Israel Innovative Technology ETF

Start Up Cannabis Nation (Podcast Transcript)

Earlier this month, cannabis growers Aphria (NASDAQ:APHA) and Tilray (NASDAQ:TLRY) announced a merger to create the largest enterprise in the industry by revenue.

Aphria CEO Talks Up Tilray Deal, Expects To Be EBIDTA-Positive And 'Not Burning Cash'

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks in the final week of 2020, and look ahead to how the cannabis industry will develop in the new year.

4 Smoking Hot Cannabis Stocks Rolling Into 2021

Israel is the largest consumer of medical cannabis in the world, but regulatory progress towards full legalization is moving slowly. Saul Kaye, CEO and founder of iCAN, talks Israel's rapidly developing industry, Covid's impact and why regulators shouldn't forget the underground market.

Start Up Cannabis Nation (Podcast)

Two leading cannabis companies just announced a business combination creating the largest publicly traded entity in the sector based on total revenue.

Does 1+1=3 for This Merger Between Two Cannabis Heavyweights?

As the marijuana industry gains legitimacy, things are going to change.

4 Cannabis Trends That Will Dominate in 2021

News for Tilray Brands Stock (TLRY)